Ta/sub 2/Zn/sub 3/O/sub 8/
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... Fe 3 O 4 @Au composite ...Fe 3 O 4 @Au composite MNPs after intraperitoneal administration in mice was ...1, 2, 3, and 4 weeks after liver injection and no behavioral ...
15
Combination of PEI-Mn<sub>0.5</sub>Zn<sub>0.5</sub>Fe<sub>2</sub>O<sub>4</sub> nanoparticles and pHsp 70-<em>HSV</em>-<em>TK</em>/GCV with magnet-induced heating for treatment of hepatoma
... Figure 3, RT- PCR using mRNA from SMMC-7721 cells transfected and heated display two distinct genetic fragments of 496 bp and 110 kb, which corresponded to the lengths of HSV-TK and GAPDH, ...
15
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... ratio 8 mL blood to 10 mL normal saline). Fe 3 O 4 was washed twice with distilled water, dried, and suspended using normal saline (final concentration ...
10
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Notes: (A) cell viability of l929 cells incubated with different concentrations (10 µM, 1 µM, and 100 nM) of the gd-NPs for 24 and 48 hours. (B) apoptosis rates of Raw264.7 cells were measured by flow cytometry at 48 ...
11
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... (FeCl 2 ⋅ 4H 2 O $ 99%) and iron (III) chloride hexahy- drate (FeCl 3 ⋅ 6H 2 O, 99%) were purchased from Merck KGaA (Darmstadt, ...
12
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... Fig. 3 show that the average particle size of the perovskite calcined in hydrogen is slightly smaller than the perovskite calcined in the ...0.1 O 3 samples were investigated particle size of gold ...
12
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... lipoprotein. 8 Higher blood level of triglycerides (TG), very low-density lipoproteins (VLDL) and intermediate-density lipoproteins (IDL), as well as lower level of high-density lipoproteins (HDL), has been shown ...
16
<p>Prostate Cancer Cellular Uptake of Ternary Titanate Nanotubes/CuFe<sub>2</sub>O<sub>4</sub>/Zn-Fe Mixed Metal Oxides Nanocomposite</p>
... Figure 6 provides three TEM images (a, b &c) after 48 hrs of incubation. Overall, it con fi rmed factual details of the ultra-structural reforms of the PC-3 cells. For example, Figure 6A exhibits a heap of the ...
13
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... functional positions provided by PLGA for loading DOX onto DMP. Enhanced drug loading is due to the increased number of functional “arms” on the DMP surface. More functional arms could provide more functional positions ...
9
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... a 2-week acclimatization for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm Fe@Si NP-exposure ...
16
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... Fe 3 O 4 @SiO 2 modified with anti-mesothelin antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro (human pancreatic cancer cell line SW1990) and in ...
13
An investigation into the efficacy of intra-articular ozone (O<sub>2</sub>–O<sub>3</sub>) injection in patients with knee osteoarthritis: a systematic review and meta-analysis
... least 2 months of follow-up ...at 2- to 3- and 4- to 6-month F/U, respectively, again in favor of control ...least 3–6 months, in mild or moderate knee OA ...
14
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... AgNO 3 and butylamine at a molar ratio of ...AgNO 3 and butylamine were added to the Fe 3 O 4 @SiO 2 ethanol solution, abundant and small Ag seeds were deposited uniformly on the SiO ...
18
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Fe 3 O 4 ...Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...Fe 3 O 4 -MNPs/DNR was ...Fe 3 O 4 -MNPs/ DNR groups were ...Fe 3 O 4 -MNPs/DNR ...
6
<p>La<sub>2</sub>O<sub>3</sub> Nanoparticles Induce Reproductive Toxicity Mediated by the Nrf-2/ARE Signaling Pathway in Kunming Mice</p>
... onto 8% sodium dodecyl sulfate (SDS) polyacrylamide gel, separated, and transferred to a ...for 2 h at room ...washed 3 times in TBST for 10 min, and incubated with horseradish peroxidase-conjugated ...
17
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... Fe 2 (SO 4 ) 3 (molar ratio 2:1) in 700 mL of distilled water under intensive stirring at a rate of 4 mL/min until the pH had increased to ...
11
<p>Local ozone (O<sub>2</sub>–O<sub>3</sub>) versus corticosteroid injection efficacy in plantar fasciitis treatment: a double-blinded RCT</p>
... Mahindra et al compared the effect of PRP versus corti- costeroid and placebo in the treatment of chronic plantar fasciopathy. 35 In this study, local injection of PRP was more, or at least as effective as ...
9
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... Fe 3 O 4 @SiO 2 /PEI, Fe 3 O 4 @SiO 2 / PEI/Sc shRNA, or Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA was incubated with the cells in serum-free medium for 6 hours, and ...
13
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... Fe 3 O 4 MNPs and changes in their tissue concentrations in the liver and ...Fe 3 O 4 MNPs were ingested by mononuclear macrophages in the liver or spleen after being absorbed into the blood, ...
6
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Fe 3 O 4 -based poly(lactic-co- glycolic acid) (PLGA) nanoparticles (NPs) surface-modified with a cyclic Arg-Gly-Asp (cRGD) peptide as an MR contrast agent for the detection of ...Fe 3 O 4 ...
14